At Neupulse, our mission is to develop technology that supports wellbeing and quality of life for people affected by neurological conditions.

As we continue to progress through the appropriate regulatory pathways for our medical device, we are also exploring how our technology can be made available through wellness-focussed applications, such as the Neupulse C. This approach allows us to continue learning from our community, expand access responsibly and further develop our platform while longer-term regulatory processes continue.

We remain committed to advancing our medical device programme in line with applicable regulatory requirements in both the UK and the United States. These processes are important to help ensure that any future medical claims are supported by appropriate evidence and that our products meet the expected standards for safety, quality and performance.

While we are not yet able to provide timelines regarding potential availability of Neupulse C or our regulatory approval in the US, we would love to keep you updated as our work progresses. The best way to stay informed is to subscribe to our newsletter, follow us on social media or visit our FAQ page for the latest updates.

We deeply appreciate your support and look forward to sharing more as we continue to develop. If you have any questions, please contact us at enquiries@neupulse.co.uk